Filtered By:
Management: Funding
This page shows you your search results in order of date. This is page number 9.
Order by Relevance | Date
Total 373 results found since Jan 2013.
Startup gobbles up $60M from high-profile investors to target food allergies
A narrow band of proteins that run through dozens of food allergies helped a Peninsula startup swallow $60 million from a syndicate of investors — including high-powered families — to develop a broad food allergy treatment.
Alladapt Immunotherapeutics Inc. — a Menlo Park company launched in 2018 by early 23andMe Inc. executive Ashley Dombkowski — expects to use the Series C funding to take its lead drug into a clinical trial later t his year. The oral drug is designed to provoke an immune…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 21, 2020 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial
Publication date: Available online 19 February 2020Source: The LancetAuthor(s): Håvard Ove Skjerven, Eva Maria Rehbinder, Riyas Vettukattil, Marissa LeBlanc, Berit Granum, Guttorm Haugen, Gunilla Hedlin, Linn Landrø, Benjamin J Marsland, Knut Rudi, Kathrine Dønvold Sjøborg, Cilla Söderhäll, Anne Cathrine Staff, Kai-Håkon Carlsen, Anna Asarnoj, Karen Eline Stensby Bains, Oda C Lødrup Carlsen, Kim M Advocaat Endre, Peder Annæus Granlund, Johanne Uthus HermansenSummaryBackgroundSkin emollients applied during early infancy could prevent atopic dermatitis, and early complementary food introduction might reduce food all...
Source: The Lancet - February 21, 2020 Category: General Medicine Source Type: research
Startup gobbles up $60M from high-profile investors to target food allergies
A narrow band of proteins that run through dozens of food allergies helped a Peninsula startup swallow $60 million from a syndicate of investors — including high-powered families — to develop a broad food allergy treatment.
Alladapt Immunotherapeutics Inc. — a Menlo Park company launched in 2018 by early 23andMe Inc. executive Ashley Dombkowski — expects to use the Series C funding to take its lead drug into a clinical trial later t his year. The oral drug is designed to provoke an immune…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 20, 2020 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
NIH Slated for 7 percent Budget Cut
The President has proposed a $38.7 billion budget for the National Institutes of Health in fiscal year (FY) 2021. This translates to a $3 billion or 7 percent cut in the agency’s funding compared to FY 2020.
The NIH budget request includes a $50 million initiative to use artificial intelligence (AI) to develop a better understanding of the causes of chronic diseases and to identify early treatments. This plan is in line with the Administration’s “Industries of the Future” effort, which supports using and developing AI across sectors.
The budget would provide $50 million for the Childhood Cancer ...
Source: Public Policy Reports - February 18, 2020 Category: Biology Authors: AIBS Source Type: news
Past Outbreaks Provide a Roadmap for U.S. Government Response to Coronavirus Threat
While the threat of the new coronavirus in the United States remains limited, a network of U.S. government agencies are already furiously ramping up efforts to contain the disease, should an outbreak occur.
“We are working to keep the risk low,” said Health and Human Services Secretary Alex Azar, who is leading the federal government’s response, at a press conference Friday. So far, the overwhelming number of new cases of the virus, which originated in Wuhan, China, remain in China. There are only 11 confirmed cases in the U.S.
The good news, some officials and infectious disease experts tell TIME, is t...
Source: TIME: Health - February 4, 2020 Category: Consumer Health News Authors: Abigail Abrams Tags: Uncategorized Source Type: news
Wuhan Coronavirus Could Test the Trump Administration ’s Ability to Respond to a Crisis. Experts are Worried
As a new strain of coronavirus moves from the Wuhan province of China to other parts of the world, including the United States, public health leaders are advising government officials to embrace a deliberate, measured response.
But with President Donald Trump at the helm of an often unpredictable administration, infectious disease and epidemic experts tell TIME they’re concerned about which officials will have the President’s ear, and how the Commander-in-Chief will manage his Twitter presence during a potential pandemic.
On Friday, Health and Human Services Secretary Alex Azar announced that, against the advi...
Source: TIME: Health - January 31, 2020 Category: Consumer Health News Authors: Abigail Abrams Tags: Uncategorized 2019-nCoV Infectious Disease White House Source Type: news
Wuhan Coronavirus Infections Have Now Surpassed the Official Number of SARS Cases in China
Chinese officials confirmed Wednesday that the number of people infected by a new form of coronavirus in the country has reached 5,974, a total that surpasses the official cases tallied on the mainland during an outbreak of severe acute respiratory syndrome (SARS) in 2002 and 2003. SARS infected 5,237 people in mainland China, and killed almost 800 people across the world.
The new SARS-like form of coronavirus has killed 132 people in China. The disease, which is believed to have originated in a seafood market in the Chinese central city of Wuhan, has also spread to other countries, including the U.S., where five cases hav...
Source: TIME: Health - January 27, 2020 Category: Consumer Health News Authors: Sanya Mansoor and Amy Gunia Tags: Uncategorized China Infectious Disease onetime overnight Source Type: news
Duke Clinical Research Institute lands $100M+ federal contract
Just in time to wrap up 2019, a Triangle contract research organization has been awarded a $102 million federal contract to bolster its revenue stream.
Durham-based Duke Clinical Research Institute (DCRI) has announced the award from the National Institute of Allergy and Infectious Diseases (NIAID) – a part of the National Institutes of Health (NIH).
The funding – spread over seven years – is directed at the Antibacterial Resistance Leadership Group (ALRG) – a research network for…
Source: bizjournals.com Health Care:Biotechnology headlines - December 16, 2019 Category: Biotechnology Authors: Seth Thomas Gulledge Source Type: news
NIH renews funding for the Antibacterial Resistance Leadership Group
(NIH/National Institute of Allergy and Infectious Diseases) As antibiotic-resistant bacteria become more urgent threats worldwide, the National Institute of Allergy and Infectious Diseases will provide up to $102.5 million in renewed funding over seven years for the Antibacterial Resistance Leadership Group (ARLG). This global consortium of scientific experts leads a comprehensive clinical research network overseeing research on important scientific questions related to antibacterial resistance.
Source: EurekAlert! - Infectious and Emerging Diseases - December 13, 2019 Category: Infectious Diseases Source Type: news
Erratum
In the article “The Role of the Skin Microbiome in Atopic Dermatitis” by Nakatsuji T et al (Ann Allergy Asthma Immunol 2019;122:263-269), there were errors in the funding and conflict of interest disclosure. The correct grant number is AR064781 and the correct disclosure is R.L.G. is a co-founder, scientific advisor, consultant, and has equity in MatriSys Biosciences and is a consultant, receives income, and has equity in Sente.
Source: Annals of Allergy, Asthma and Immunology - October 30, 2019 Category: Allergy & Immunology Tags: Erratum Source Type: research
Meet the Health Officials Who Alerted the World to the Alarming Vaping Illness Meet the Health Officials Who Alerted the World to the Alarming Vaping Illness
It ' s a tale of teamwork, communication, and long-serving public health officials tapping into their networks in an era of limited public health funding.Kaiser Health News
Source: Medscape Allergy Headlines - October 3, 2019 Category: Allergy & Immunology Tags: Pulmonary Medicine News Source Type: news
Stem Cell Agency to Ask for New Funds Despite Failed Promises Stem Cell Agency to Ask for New Funds Despite Failed Promises
California ' s stem cell agency is almost out of money. Its supporters plan to ask voters for more funding next year, even though no agency-funded treatments have been approved for widespread use.Kaiser Health News
Source: Medscape Allergy Headlines - August 20, 2019 Category: Allergy & Immunology Tags: Pathology & Lab Medicine News Source Type: news
